Patents
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
06/2006
06/21/2006CN1260227C 5-membered ring heterocyclic compounds with nitrogen
06/21/2006CN1260225C Tetrahydropyridino or piperidino hetlrocyclic derivatives
06/21/2006CN1260222C Antagonists of mcp-1 function and methods of use thereof
06/20/2006USRE39140 pyridylmethylamines such as 1-(2-chloro-5-thiazolylmethyl)-2-cyanoiminoimidazolidine used as insecticides
06/20/2006US7064207 Androgen receptor antagonists
06/20/2006US7064144 Imidazole derivatives as adenosine deaminase inhibitors
06/20/2006US7064142 Imidazonline compounds
06/20/2006US7064137 Analgesics; anxiolytic agents; gastrointestinal disorders
06/20/2006US7064136 Central nervous system disorders; psychological disorders; schizophrenia; antiarthritic agents; Alzheimer's disease; anticancer agents
06/20/2006US7064121 benzodiazepine derivatives that may be fused to a pyrroline or piperidine ring; e.g., N-[1 (R)-(3-Aminopropylcarbamoyl)-2-(naphthalen-2-yl)ethyl]-3-(5,11-dioxo-2,3-dihydro-1H-(11aS)-pyrrolo[2,1-c][1,4]benzodiazepin-10-yl)propionamide; increasing levels of endogenous growth hormones in humans and animals
06/20/2006US7064118 Cholinergic ligands of the nicotinic acetyl choline receptors; modulators; nervous system disordes, analgesics; smooth muscle contraction; antiinflammatory agents; drug abuse, including smoking; Alzheimer's disease; Parkinson's disease; cognition
06/15/2006WO2006062984A2 Inhibitors of protein kinases
06/15/2006WO2006062982A2 Urea inhibitors of map kinases
06/15/2006WO2006062478A1 Novel treatment of gastrointestinal disorders
06/15/2006WO2006062224A1 Carboxamide derivative
06/15/2006WO2006062093A1 Novel anthranilic acid derivative or salt thereof
06/15/2006WO2006061200A1 Anthranilamide derivatives as insecticides
06/15/2006WO2005113526A3 Metabolites of 4-(3,4-dichloro-phenyl)-2-[2-(4-methyl-piperazin-1-yl)-benzylidene]-thiomorpholin-3-one
06/15/2006WO2005097112A3 Ion channel modulators
06/15/2006US20060128966 Thia-epothilone derivatives for the treatment of cancer
06/15/2006US20060128963 Piperidine derivatives as melanocortin-4 receptor agonists
06/15/2006US20060128961 Process for the production of meso-substituted cyanine dyes
06/15/2006US20060128957 Fluorous tagging and scavenging reactants and methods of synthesis and use thereof
06/15/2006US20060128772 2-(2-methoxyphenyl)-3-(2-methoxy-phenyl)-5-phenylamino-(1,2,4)-thiadiazol-2 -ium; metabolic, nervous system and dermatological disorders, antidiabetic; obesity, impaired oral glucose tolerance, type II diabetes and Syndrome X, acne, dry skin and seborrheic dermatitis
06/15/2006US20060128770 Thiazole derivatives
06/15/2006US20060128768 Furanthiazole derivatives as heparanase inhibitors
06/15/2006US20060128761 Novel triazole compounds as transforming growth factor (TGF) inhibitors
06/15/2006US20060128754 tubulysin derivatives used as antitumor agents
06/15/2006US20060128750 Targeting chemokine receptors and interfere with the binding of the natural ligand thereto; antagonists or agonists; protecting target cells from HIV infection; treating HIV or FIV infected patients
06/15/2006US20060128747 To treat Gram-positive bacterial infections; antibacterial and/or antifungal properties; Preferably drug-resistant strains of bacteria
06/15/2006US20060128722 Indoles useful in the treatment of androgen-receptor related diseases
06/15/2006US20060128717 Therapeutic agents useful for treating pain
06/15/2006US20060128712 Phenyl-piperazine methanone derivatives, substituted by heterocyclic groups
06/15/2006US20060128706 Apoptosis promoters
06/15/2006US20060128701 N-{4-[ethyl-(2-hydroxy-ethyl)-amino]-phenyl}-2-[4-(2-oxo-4H-benzo[d][1,3]oxazin-1- yl)-piperidin-1-yl]-acetamide; Eating disorders; CNS disorders; antidiabetic agents; psychological disorders; antiepileptic, antiinflammatory agents, autoimmune diseases; neuropeptide Y5 (NPY5) receptor antagonists
06/15/2006US20060128695 Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses
06/15/2006US20060128687 Lactam glycogen phosphorylase inhibitors and method of use
06/15/2006US20060128685 Pyrazole derivative
06/15/2006US20060128684 Anthranilic acid amide derivatives and their pharmaceutical use
06/15/2006US20060128669 3-(4-Fluorobenzyl)-8-hydroxy-quinoline-5,7-dicarboxylic acid 7-methylester; against Human T Cell leukemia virus, Feline and Simian immunodeficiency viruses, AIDS and related clinical symptoms
06/15/2006US20060128642 Pesticides, controlling animal pests
06/15/2006CA2590811A1 Heterocycle derivatives as histone deacetylase (hdac) inhibitors
06/15/2006CA2589274A1 Inhibitors of protein kinases
06/15/2006CA2588633A1 Novel anthranilic acid derivative or salt thereof
06/14/2006EP1669070A2 2-imino-thiazolidine and -oxazolidine derivatives for use as antiinflammatory agents
06/14/2006EP1669069A1 Compounds effecting glukokinase
06/14/2006EP1669068A1 Compounds effecting Glucokinase
06/14/2006EP1668162A1 Detection of immobilized nucleic acid
06/14/2006EP1668008A2 Nitrosated ad nitrosylated diuretic compouds, compositions and methods of use
06/14/2006EP1668007A1 Dioxolane derivatives as cell adhesion inhibitors
06/14/2006EP1668005A1 Acyloxymethylcarbamate prodrugs of oxazolidinones
06/14/2006EP1667997A1 Pyrimidine and pyridine derivatives useful as hmg-coa reductase inhibitors and method of preparation thereof
06/14/2006EP1667995A1 Benzimidazole acetonitriles
06/14/2006EP1667994A1 Quinolone antibacterial agents
06/14/2006EP1667993A1 Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them
06/14/2006EP1667984A1 Gamma-secretase inhibitors
06/14/2006EP1667981A1 Isoquinoline potassium channel inhibitors
06/14/2006EP1667980A1 1,4-disubstituted isoquinoline derivatives as raf-kinase inhibitors useful for the treatment of proliferative diseases
06/14/2006EP1667977A1 Isoquinolinone potassium channel inhibitors
06/14/2006EP1667970A1 Heterocyclic- or aryloxy, -thio 0r -amino substituted indoles-2-carboxylic acids or esters as pai-1 inhibitors
06/14/2006EP1667643A2 Nitrosated and nitrosylated cardiovascular compounds, compositions and methods of use
06/14/2006EP1667635A2 Sulfonylaminovalerolactams and derivatives thereof as factor xa inhibitors
06/14/2006EP1446404B1 Rosiglitazone edisylates and their use as antidiabetics
06/14/2006EP1399439B1 2-heteroaryl-imidazotriazinones and their use in the treatment of inflammatory or immune diseases
06/14/2006EP1309564B1 Arylethene-sulfonamides, their preparation and their use as endothelin antagonists
06/14/2006EP1268418B1 Pharmaceutically active pyrrolidine derivatives as bax inhibitors
06/14/2006CN1788000A Phthalazinone derivatives
06/14/2006CN1787998A Method for producing bipyridinium compound
06/14/2006CN1787997A 4-arylsulphonylpiperidine derivatives for antagonism of the 5-HT2A receptor
06/14/2006CN1787989A Imino ether derivative compounds and drugs containing the compounds as the active ingredient
06/14/2006CN1785983A Benzo [1,2,3] thiadiazole derivative its synthesis method and use
06/14/2006CN1259318C Tetrazoyl oxime derivative and agrochemical containing the same as active ingredient
06/14/2006CN1259315C Antagonists of MCP-1 function and methods of use thereof
06/13/2006USRE39131 Heterocyclic compounds
06/13/2006USRE39130 iNSECTICIDES; CONTAINING A 2-CYANOIMINO GROUP ON HETEROCYCLIC RING
06/13/2006USRE39129 Insecticides; containing a 2-cyanoimino group attached to heterocyclic ring
06/13/2006USRE39127 Heterocyclic compounds
06/13/2006US7060850 Fluorous tagging and scavenging reactants and methods of synthesis and use thereof
06/13/2006US7060834 Using a 2-aminoquinoline compound
06/13/2006US7060827 Intermediates useful for making 2,4-pyrimidinediamine compounds
06/13/2006US7060722 Proline derivatives and use thereof as drugs
06/13/2006US7060720 Compounds useful for treating or preventing IMPDH associated disorders, such as transplant rejection and autoimmune diseases and inhibitors of inosine-5'-monophosphate dehydrogenase). The compounds and pharmaceutical compositions
06/13/2006US7060701 piperidines or piperazines 1-linked to a 1-(1-carbonylpiperidin-4-yl)piperidinyl- group through an optionally substituted methyl group; treating Human Immuno-deficiency Virus, solid organ transplant rejection, arthritis, rheumatoid arthritis, and multiple sclerosis
06/13/2006CA2249562C Certain fused pyrrolecarboxamides as gaba brain receptor ligands
06/13/2006CA2238723C Arylethenesulfonamide derivatives and drug composition containing the same
06/13/2006CA2158981C Herbicidal heterocyclic-substituted pyridines
06/08/2006WO2006060424A2 Inducible nitric oxide synthase dimerization inhibitors
06/08/2006WO2006060381A2 N-substituted benzimidazolyl c-kit inhibitors and combinatorial benzimidazole library
06/08/2006WO2006058720A2 Novel compounds for the treatment of neurological disorders
06/08/2006WO2006058630A1 Cyclic iminocarbamates and use thereof
06/08/2006US20060123404 Computer program code size partitioning system and method for multiple memory multi-processing systems
06/08/2006US20060122432 Aryl piperidine derivatives and use thereof to reduce elevated levels of ldl-cholesterol
06/08/2006US20060122399 Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same
06/08/2006US20060122397 Exhibiting an activity at metabotropic glutamate receptors (mGluRs), especially at the mGluR5 receptor; neurological disorders, psychiatric disorders, acute and chronic pain
06/08/2006US20060122387 Derivatives of chromen-2-one as inhibitors of vegf production in mammalian cells
06/08/2006US20060122245 Novel inhibitors of IMPDH enzyme
06/08/2006US20060122242 2-Aryloxy-2-arylalkanoic acids for diabetes and lipid disorders
06/08/2006US20060122241 Novel macrocycles for the treatment of cancer diseases
06/08/2006US20060122234 Substituted thienyl-hydroxamic acids as histone deacetylase inhibitors
06/08/2006US20060122229 4,5-diarylthiazole derivatives as cb-1 ligands